Legis Daily

America First Vaccine Act

USA116th CongressS-4542| Senate 
| Updated: 9/9/2020
Thomas Tillis

Thomas Tillis

Republican Senator

North Carolina

Banking, Housing, and Urban Affairs Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
America First Vaccine Act This bill prohibits a U.S.-headquartered manufacturer of a COVID-19 (i.e., coronavirus disease 2019) vaccine that was developed with federal pandemic relief funding from distributing it outside of the United States, unless the Department of Health and Human Services (HHS) certifies that domestic need for the vaccine already has been met. However, HHS may waive the certification requirement and permit distribution outside of the United States if HHS makes a determination that such distribution would be in the interest of U.S. public health. A manufacturer that violates the requirement must reimburse the federal government for all amounts received by the manufacturer in support of development of the vaccine, plus interest.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 9, 2020
Introduced in Senate
Sep 9, 2020
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
  • September 9, 2020
    Introduced in Senate


  • September 9, 2020
    Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

Health

Cardiovascular and respiratory healthEmergency medical services and trauma careHealth programs administration and fundingImmunology and vaccinationInfectious and parasitic diseasesManufacturingTrade restrictions

America First Vaccine Act

USA116th CongressS-4542| Senate 
| Updated: 9/9/2020
America First Vaccine Act This bill prohibits a U.S.-headquartered manufacturer of a COVID-19 (i.e., coronavirus disease 2019) vaccine that was developed with federal pandemic relief funding from distributing it outside of the United States, unless the Department of Health and Human Services (HHS) certifies that domestic need for the vaccine already has been met. However, HHS may waive the certification requirement and permit distribution outside of the United States if HHS makes a determination that such distribution would be in the interest of U.S. public health. A manufacturer that violates the requirement must reimburse the federal government for all amounts received by the manufacturer in support of development of the vaccine, plus interest.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 9, 2020
Introduced in Senate
Sep 9, 2020
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
  • September 9, 2020
    Introduced in Senate


  • September 9, 2020
    Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Thomas Tillis

Thomas Tillis

Republican Senator

North Carolina

Banking, Housing, and Urban Affairs Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Cardiovascular and respiratory healthEmergency medical services and trauma careHealth programs administration and fundingImmunology and vaccinationInfectious and parasitic diseasesManufacturingTrade restrictions